XML 32 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements Of Cash Flows (USD $)
9 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Cash Flows from Operating Activities:    
Net loss $ (4,964,435) $ (3,619,249)
Adjustments to reconcile net loss to cash provided by operating activities of continuing operations:    
Income (loss) from discontinued operations 2,765,300 (210,525)
Depreciation and amortization 458,921 486,631
Goodwill impairment 0 905,810
Compensation expense related to stock options 56,868 87,156
(Income) Loss from Ocular Telehealth Management, LLC (612) 71,745
Change in operating assets and liabilities:    
Accounts receivable, net 349,914 622,300
Inventory, net 720,787 (447,958)
Other current and long-term assets 74,948 251,858
Accounts payable and accrued expenses (112,555) (57,333)
Net cash used in operating activities from continuing operations (650,864) (1,909,565)
Net cash used in (provided by) operating activities from discontinued operations (566,953) 1,024,365
Net cash used in operating activities (1,217,817) (885,200)
Cash Flows from Investing Activities:    
Investment in Ocular Telehealth Management, LLC 0 (45,000)
Purchase of fixed assets (66,723) (96,805)
Net cash (used in) investing activities (66,723) (141,805)
Cash Flows from Financing Activities:    
Principal payments on long-term debt (155,795) (50,538)
Proceeds from related party note payable 300,000 0
Net cash provided by (used in) financing activities 144,205 (50,538)
Effect of exchange rate changes on cash & cash equivalents 18,469 205,122
Net decrease in cash and cash equivalents (1,121,866) (872,421)
Cash and cash equivalents, beginning of period 1,684,746 3,008,485
Cash and cash equivalents, end of period 562,880 2,136,064
Supplemental Schedule of Cash Flow Information:    
Interest paid 170,550 168,694
Income taxes paid   $ 45,000